Supplements

Ipamorelin (10MG)

• 27/100 science score
• $97.99 price
• Promoted by Ben Greenfield

Overview

Effectiveness rated low due to strong preclinical GH-releasing data but absent human trials for primary claims (muscle gain, fat loss). Key studies: animal potency (PubMed 9849822, ED50 2-80 nmol/kg); human PK/PD (Springer 1999, GH peaks but short-lived); failed ileus RCT (PubMed 25331030, no efficacy). Safety penalized for FDA Category 2 status with death-linked AEs, no approval, and compounding recalls despite short-term tolerability. Quality low: no standardized testing, variable vendor purit

Key strengths

• Potent selective GH secretagogue with minimal cortisol/prolactin rise vs other GHRPs
• Short-term tolerability in human PK studies
• Potential synergy with GHRH analogs like CJC-1295

Our analysis

Avoid Ipamorelin due to insufficient clinical evidence for effectiveness in healthy adults and FDA-identified safety risks including serious adverse events. Short-term GH stimulation shown but no proven benefits for muscle/fat; long-term risks unknown. Safer alternatives like lifestyle or approved GH therapies preferred.

Frequently asked questions

Is Ipamorelin (10MG) worth buying?

Ipamorelin (10MG) has a Verify Influencers trust score of 27/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for Ipamorelin (10MG)?

Ipamorelin (10MG) scored 27 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored